{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "Y",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "OBZ",
      "openfda": {
        "k_number": [
          "K213396",
          "K063498"
        ],
        "registration_number": [
          "1618982",
          "8023024"
        ],
        "fei_number": [
          "1618982",
          "6387"
        ]
      },
      "review_panel": "IM",
      "medical_specialty": "IM",
      "device_name": "Alpha-1-Antitrypsin Kit, Qualitative Phenotype",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Immunology",
      "device_class": "2",
      "definition": "The alpha-1-antitrypsin qualitative phenotype test result is used as an aid in the diagnosis of alpha-1-antitrypsin deficiency in conjunction with clinical and other laboratory findings. For in vitro diagnostic use only.",
      "regulation_number": "866.5130",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}